Federal drug price watchdog consulting public on proposed changes to its pricing guidelines
Imported from official source
The Patented Medicine Prices Review Board (PMPRB) released its new draft Guidelines today and launched a 60-day consultation period with stakeholders and interested members of the public.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
94e703277ab56cd231284602d8e826d8- All versions
- Revision history